Another highly relevant activity for cancer progression is the ability of CDK4 and CDK6 to suppress senescence by phosphorylating FOXM1, maintaining cell cycle progression and preventing tumor suppressive mechanisms. This evidence concerns the gene CDK4 and neoplasm.